277 related articles for article (PubMed ID: 23775078)
1. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.
Cai Y; Balli D; Ustiyan V; Fulford L; Hiller A; Misetic V; Zhang Y; Paluch AM; Waltz SE; Kasper S; Kalin TV
J Biol Chem; 2013 Aug; 288(31):22527-41. PubMed ID: 23775078
[TBL] [Abstract][Full Text] [Related]
2. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice.
Kalin TV; Wang IC; Ackerson TJ; Major ML; Detrisac CJ; Kalinichenko VV; Lyubimov A; Costa RH
Cancer Res; 2006 Feb; 66(3):1712-20. PubMed ID: 16452231
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
Liu Y; Liu Y; Yuan B; Yin L; Peng Y; Yu X; Zhou W; Gong Z; Liu J; He L; Li X
Oncotarget; 2017 Mar; 8(10):17027-17037. PubMed ID: 28199985
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis.
Wang IC; Meliton L; Ren X; Zhang Y; Balli D; Snyder J; Whitsett JA; Kalinichenko VV; Kalin TV
PLoS One; 2009 Aug; 4(8):e6609. PubMed ID: 19672312
[TBL] [Abstract][Full Text] [Related]
6. Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer.
Wang Y; Yao B; Wang Y; Zhang M; Fu S; Gao H; Peng R; Zhang L; Tang J
Int J Mol Med; 2014 Jun; 33(6):1514-22. PubMed ID: 24676803
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of FoxM1 by HIF‑1α mediates hypoxia‑induced EMT in prostate cancer.
Tang C; Liu T; Wang K; Wang X; Xu S; He D; Zeng J
Oncol Rep; 2019 Oct; 42(4):1307-1318. PubMed ID: 31364741
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
Wierstra I
Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
[TBL] [Abstract][Full Text] [Related]
9. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma.
Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M
J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.
Liu Y; Gong Z; Sun L; Li X
Biochim Biophys Acta; 2014; 1839(4):297-305. PubMed ID: 24583551
[TBL] [Abstract][Full Text] [Related]
12. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor FOXF1 promotes prostate cancer by stimulating the mitogen-activated protein kinase ERK5.
Fulford L; Milewski D; Ustiyan V; Ravishankar N; Cai Y; Le T; Masineni S; Kasper S; Aronow B; Kalinichenko VV; Kalin TV
Sci Signal; 2016 May; 9(427):ra48. PubMed ID: 27165781
[TBL] [Abstract][Full Text] [Related]
14. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
Liu Y; Hock JM; Van Beneden RJ; Li X
Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
[TBL] [Abstract][Full Text] [Related]
15. P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.
Li T; Wang F; Dang Y; Dong J; Zhang Y; Zhang C; Liu P; Gao Y; Wang X; Yang S; Lu S
Int J Biol Sci; 2019; 15(10):2198-2210. PubMed ID: 31592235
[TBL] [Abstract][Full Text] [Related]
16. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
17. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
[TBL] [Abstract][Full Text] [Related]
18. FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression.
Cheng SX; Tu Y; Zhang S
PLoS One; 2013; 8(8):e72376. PubMed ID: 23991102
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of FOXM1 in human prostate cancer (Review).
Lee DY; Chun JN; So I; Jeon JH
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 38038123
[TBL] [Abstract][Full Text] [Related]
20. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]